ENTITY
Changchun High-Tech
Changchun High-Tech
PulseAugur coverage of Changchun High-Tech — every cluster mentioning Changchun High-Tech across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
SENTIMENT · 30D
2 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Shenzhen offers smart product subsidies; AI to revolutionize drug development
Shenzhen is offering a 15% subsidy, capped at 1500 yuan, for purchases of smart home and other smart products in 2026. This initiative aims to encourage consumers to buy new, qualifying items. Separately, J.P. Morgan ho…
-
Changchun High-Tech subsidiary's drug gets FDA nod for US clinical trials
Changchun High-Tech's subsidiary, Gensci Pharmaceutical, has received approval from the U.S. FDA to commence clinical trials for its GenSci161 injection. This fully human bispecific antibody targets both IL-1α and IL-1β…